Priya Kishnani
Pediatrics · Durham, NCNPI 1114001021
Payments from drug & device makers
Across 1,016 payments — averaging $20,029 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$9.1M
- Amicus Therapeutics, Inc.$4.2M
- Asklepios Biopharmaceutical Inc.$2.8M
- Alnylam Pharmaceuticals Inc.$2M
- AstraZeneca$593K
- Sanofi US Services Inc.$542K
- plus $1.1M from 14 others
Across 86 payments — averaging $1376.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$118K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 363 | $9,126,290 |
| Amicus Therapeutics, Inc. | 306 | $4,189,675 |
| Asklepios Biopharmaceutical Inc. | 2 | $2,780,494 |
| Alnylam Pharmaceuticals Inc. | 24 | $1,990,300 |
| AstraZeneca | 132 | $593,076 |
| Sanofi US Services Inc. | 54 | $542,118 |
| Bayer | 1 | $379,189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $296,963 |
| Ultragenyx Pharmaceutical Inc. | 1 | $230,937 |
| Shire North American Group Inc | 35 | $92,237 |
| Sanofi-aventis U.S. LLC | 19 | $72,805 |
| Biomarin Pharmaceutical Inc. | 11 | $19,712 |
| Chiesi USA, Inc. | 2 | $10,695 |
| Swedish Orphan Biovitrum AB | 1 | $10,350 |
| Regeneron | 8 | $5,868 |
| Bioverativ Therapeutics Inc. | 2 | $3,227 |
| F. Hoffmann-la Roche AG | 1 | $2,540 |
| Modernatx, Inc. | 1 | $2,320 |
| Cycle Pharmaceuticals Inc | 1 | $675 |
| Eli Lilly | 1 | $118 |
How this compares
$20,349,589 in reported general payments places this provider in the 95th percentile of 1,818 pediatrics providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatrics in Durham
- Dwight KoeberlDurham$9.2M
- Emmanuel WalterDurham$8M
- Edward SmithDurham$2.8M
- Rasheed GbadegesinDurham$1M
- Consuelo RabinovichDurham$283K
- David VanmaterDurham$253K
- Michael FreemarkDurham$218K
- Daniel LandiDurham$202K
- Kathleen McGannDurham$201K
- Heather van MaterDurham$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.